We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




AI System Predicts Heart Failure Risk Years in Advance from Holter ECG

By HospiMedica International staff writers
Posted on 20 Jul 2026

Heart failure, a progressive syndrome in which the heart cannot meet the body’s circulatory demands, affects about 64 million people worldwide. More...

In developed countries, roughly 12% of adults older than 65 live with the condition, which causes fatigue, shortness of breath, edema, and exercise intolerance and can be fatal. Earlier identification before clinical onset could enable preventive treatment and reduce deterioration. To help address this challenge, researchers have developed an artificial intelligence system that predicts future heart failure risk from routine electrocardiogram data.

DeepHHF is an artificial intelligence model created at the Technion Faculty of Biomedical Engineering (Haifa, Israel). The system analyzes standard 24-hour ambulatory electrocardiogram (Holter ECG) recordings obtained during routine home Holter monitoring. It aims to flag patients at elevated risk of developing heart failure well ahead of symptom onset.

The model operates on raw Holter ECG signals and detects subtle abnormalities that are often imperceptible to the human eye. Its output provides an early warning that can precede a diagnosis by several years. By focusing on data already captured in usual care, the approach is designed to integrate with existing cardiac monitoring pathways.

In development, DeepHHF was trained on approximately 70,000 Holter examinations performed at Leumit Health Services. The study was led by the Technion and published in npj Digital Medicine on June 19, 2026. Collaborating institutions included Rambam Health Care Campus, Shaare Zedek Medical Center, the Hebrew University of Jerusalem, Leumit Health Services, and Hadassah Medical Center.

The research underscores a growing emphasis on early diagnosis to enable preventive interventions that can improve outcomes and save lives. Because the method relies on noninvasive, widely available monitoring, it may help clinicians identify high-risk patients earlier and plan proactive management. The authors report that the model can predict risk up to five years in advance using raw Holter ECG recordings.

“To the best of our knowledge, no existing model can predict the risk of heart failure up to five years in advance using raw Holter ECG recordings. By relying on standard, non-invasive diagnostic tools, our model provides clinically valuable information that enables early identification of high-risk patients and timely preventive interventions, with the potential to reduce hospitalizations, suffering and mortality,” said Prof. Joachim Behar, senior author at the Technion Faculty of Biomedical Engineering.

Related Links
Technion Faculty of Biomedical Engineering


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
Blood Gas Analyzer
i-Check200
Medical Adhesive
MED 5570U
Multi-Chamber Washer-Disinfector
WD 390
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Medical Imaging

view channel
Image: Annotation platform for pixel-level labeling of free-text findings in 3D chest CT. (Baharoon M, Luo L, Moritz M, et al. ReXGroundingCT: A 3D chest CT dataset for segmentation of findings from free-text reports. NEJM AI. 2026;3(7). doi:10.1056/AIdbp2501220.)

Public Chest CT Dataset Supports Explainable AI in Diagnostic Radiology

Chest computed tomography scans generate complex three-dimensional images that can be difficult for artificial intelligence systems to explain clearly. Clinicians need to verify AI findings before using... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: The proposed acquisition would add NeoCast, an investigational next-generation liquid embolic technology for chronic subdural hematoma (cSDH), to Terumo Neuro’s neurovascular portfolio. (Photo courtesy of Arsenal Medical)

Terumo Neuro Acquisition Advances Liquid Embolic Technology for Chronic Subdural Hematoma

Terumo Neuro (Aliso Viejo, CA, USA) signed an agreement to acquire Arsenal Medical Inc. (Waltham, MA, USA), a privately held, clinical-stage biomaterials company. The proposed acquisition would add NeoCast,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.